Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains

Shan Li1, Li Zhang, Qing Yao

  • 1College of Biological Sciences, China Agricultural University, Beijing 100094, China.

Nature
|August 20, 2013
PubMed

Insights

Enteropathogenic Escherichia coli uses NleB to inhibit host immune responses by modifying death domains, blocking crucial cell signaling pathways like NF-κB, apoptosis, and necroptosis. This bacterial mechanism, involving N-acetylglucosamine transferase activity, is vital for infection.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Tumor Necrosis Factor (TNF) signaling is critical for immune homeostasis, inflammation, and cell death.
  • TNF receptor (TNFR) family members, like TNFR1 and FAS, mediate these signals through death domains.
  • These domains interact with adaptor proteins such as TRADD and FADD to trigger downstream signaling.

Purpose of the Study:

  • To identify the mechanism by which enteropathogenic Escherichia coli (EPEC) inhibits host immune signaling.
  • To investigate the role of the EPEC type III secretion system effector NleB in modulating death receptor pathways.
  • To characterize the enzymatic activity of NleB and its impact on host cell death and inflammation.

Main Methods:

  • Biochemical assays to determine NleB's enzymatic activity.
  • Site-directed mutagenesis to identify key residues in NleB and target death domains.
  • Cell-based assays to assess NF-κB signaling, apoptosis, and necroptosis.
  • In vivo infection models to evaluate the role of NleB in bacterial colonization.

Main Results:

  • NleB possesses N-acetylglucosamine (GlcNAc) transferase activity, modifying a conserved arginine in death domains of proteins including TRADD, FADD, RIPK1, and TNFR1.
  • This GlcNAcylation inactivates death domains, preventing essential protein-protein interactions and the assembly of signaling complexes like the TNFR1 complex and DISC.
  • Disruption of TNF, NF-κB, apoptosis, and necroptosis signaling was observed in EPEC-infected cells.
  • NleB's GlcNAc transferase activity was essential for EPEC colonization in a mouse model.

Conclusions:

  • NleB from EPEC directly inhibits host TNFR and FAS signaling pathways through a novel post-translational modification (GlcNAcylation) of death domains.
  • This bacterial strategy effectively counteracts host immune responses, including inflammation and cell death.
  • The discovery of NleB's arginine GlcNAc transferase activity reveals a new mechanism of bacterial pathogenesis and an unappreciated form of protein modification.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...